Showing 81-90 of 1908 results for "".
Julie Woodward: "If I could…"
https://practicaldermatology.com/topics/practice-management/julie-woodward-if-i-could-/19052/A well known oculoplastic surgeon, Julie Woodward, MD explains what device would complement the laser and energy-based device systems she already has in her busy practice. See which device she's pick.Join the (Buying) Club
https://practicaldermatology.com/topics/practice-management/join-the-buying-club/18547/Every practice must buy a certain amount of supplies month to month. There's no getting around it. But you can save on those purchases. Among your options, consider a buying club. Jay A. Shorr, BA, MBM-C, CAC I-IX explains.Lex Icon: Lexington's Randy Waldman Speaks the Language of Successful Site Planning with Joel L. Cohen
https://practicaldermatology.com/topics/practice-management/lex-icon-lexington-s-randy-waldman-speaks-the-language-of-successful-site-planning-with-joel-l-cohen--ovevisoh/18901/How do you plan a brand new, state-of-the art surgical and clinical space that's accessible yet feels exclusive? Should you rent or buy? How do you balance your time? S. Randolph Waldman, MD answers these questions and more from series host Joel L. Cohen, MD in this edition of Best Practices.JAK Inhibitors Make the Cut for Alopecia Areata
https://practicaldermatology.com/topics/hair-nails/jak-inhibitors-make-the-cut-for-alopecia-areata/23935/JAK inhibitor approvals increase the opportunity for patients with alopecia areata to experience “life-changing” results.DERM2020 Content Recap: Julie Harper, MD
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-content-recap-julie-harper-md/19844/DERM20920 Faculty Julie Harper, MD discusses what’s new in rosacea from her presentation during DERM2020.2017 Tax Cuts and Jobs Act: What You Need to Know
https://practicaldermatology.com/topics/practice-management/2017-tax-cuts-and-jobs-act-what-you-need-to-know--vmyiwowa/18348/OJM Group principal Carole Foos, CPA provides an overview of the Tax Cuts and Jobs Act, which was signed in to law at the end of 2017. She discusses key provisions affecting individual physicians and medical practices, and offers advice to consider when planning for 2018 and beyond. Click here to reTips for dealing with patients and the media offered by Dr. Joel Schlessinger
https://practicaldermatology.com/topics/practice-management/tips-for-dealing-with-patients-and-the-media-offered-by-dr-joel-schlessinger/19155/In an increasingly connected world, business professionals must be aware of how negative customer experiences can quickly and easily be shared through the internet and social media. Dermatology is no different and Dr. Joel Schlessinger has heard of many cases in which a practice's reputation has sufJournal Club: Atopic Dermatitis Control Tool
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-atopic-dermatitis-control-tool/26734/Peter Lio, MD, talks with Lisa Swanson, MD, a board-certified dermatologist and pediatric dermatologist practicing in Boise, Idaho, about the Atopic Dermatitis Control Tool (ADCT). Highlighted in a recent study published in the British Journal of Dermatology, the ADCT has been said to provide patienJournal Club: Oral JAK Inhibitors in Moderate-to-Severe AD
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-oral-jak-inhibitors-moderate-severe-ad/24539/Peter Lio, MD, talks with Robert Sidbury, MD, MPH, a dermatologist at Seattle Children's Hospital, about nuanced differences in guideline-recommended use of oral JAK inhibitors in pediatric patients with moderate-to-severe atopic dermatitis (AD) provided in the Annals of Allergy, Asthma, and ImmunolJournal Club: Blocking IL-4/IL-13 vs JAK/STAT
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-blocking-il-4il-13-vs-jakstat/29101/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, speaks with Editorial Board member Peter Lio, MD, about the Journal of Personalized Medicine article, "Blocking the IL-4/IL-13 Axis versus the JAK/STAT Pathway in Atopic Dermatitis: How Can We Choose?"